Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Buchanan

Showing results (471-480 of 841) with videos related to

Pageof 85
Sort By:
The Journal of Nervous and Mental Disease|November 5, 1997
Failure of fusion of the septum pellucidum and the heterogeneity of schizophreniaB Kirkpatrick, D Litman, J W Kim, et al.
Psychiatry Research|August 23, 2019
Nicotine effects on cognitive remediation training outcome in people with schizophrenia: A pilot studyBritta Hahn, Megan E Shrieves, Marie B Yuille, et al.
Psychiatry Research|November 1, 1989
The Schedule for the Deficit syndrome: an instrument for research in schizophreniaB Kirkpatrick, R W Buchanan, P D McKenney, et al.
Schizophrenia Bulletin|October 14, 2003
Racial disparity in the pharmacological management of schizophreniaJulie Kreyenbuhl, Julie M Zito, Robert W Buchanan, et al.
Archives of General Psychiatry|December 1, 1992
Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structuresA Breier, R W Buchanan, A Elkashef, et al.
Clinical Science|April 1, 1971
Isotope studies in normal and diseased knee joints: 99mTc uptake related to clinical assessment and to synovial perfusion measured by the 133Xe clearance techniqueW C Dick, S D Deodhar, C J Provan, et al.
Nature|January 7, 2005
A mechanism for impaired fear recognition after amygdala damageRalph Adolphs, Frederic Gosselin, Tony W Buchanan, et al.
Neuroreport|April 27, 2004
Gamma/beta oscillation and sensory gating deficit in schizophreniaL Elliot Hong, Ann Summerfelt, Robert P McMahon, et al.
The Journal of Rheumatology|July 1, 1991
Clinical evaluation of a sustained release compared to a standard formulation of tiaprofenic acid (Surgam) in rheumatoid arthritis: a Canadian multicenter studyW W Buchanan, W F Kean, J St-Jean, et al.
Schizophrenia Research|May 18, 2013
Open-label salsalate for the treatment of pre-diabetes in people with schizophreniaWilliam R Keller, Bernard A Fischer, Robert P McMahon, et al.
Pageof 85

Showing results (471-480 of 841) with videos related to

Sort By:
Pageof 85
The Journal of Nervous and Mental Disease|November 5, 1997
Failure of fusion of the septum pellucidum and the heterogeneity of schizophreniaB Kirkpatrick, D Litman, J W Kim, et al.
Psychiatry Research|August 23, 2019
Nicotine effects on cognitive remediation training outcome in people with schizophrenia: A pilot studyBritta Hahn, Megan E Shrieves, Marie B Yuille, et al.
Psychiatry Research|November 1, 1989
The Schedule for the Deficit syndrome: an instrument for research in schizophreniaB Kirkpatrick, R W Buchanan, P D McKenney, et al.
Schizophrenia Bulletin|October 14, 2003
Racial disparity in the pharmacological management of schizophreniaJulie Kreyenbuhl, Julie M Zito, Robert W Buchanan, et al.
Archives of General Psychiatry|December 1, 1992
Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structuresA Breier, R W Buchanan, A Elkashef, et al.
Clinical Science|April 1, 1971
Isotope studies in normal and diseased knee joints: 99mTc uptake related to clinical assessment and to synovial perfusion measured by the 133Xe clearance techniqueW C Dick, S D Deodhar, C J Provan, et al.
Nature|January 7, 2005
A mechanism for impaired fear recognition after amygdala damageRalph Adolphs, Frederic Gosselin, Tony W Buchanan, et al.
Neuroreport|April 27, 2004
Gamma/beta oscillation and sensory gating deficit in schizophreniaL Elliot Hong, Ann Summerfelt, Robert P McMahon, et al.
The Journal of Rheumatology|July 1, 1991
Clinical evaluation of a sustained release compared to a standard formulation of tiaprofenic acid (Surgam) in rheumatoid arthritis: a Canadian multicenter studyW W Buchanan, W F Kean, J St-Jean, et al.
Schizophrenia Research|May 18, 2013
Open-label salsalate for the treatment of pre-diabetes in people with schizophreniaWilliam R Keller, Bernard A Fischer, Robert P McMahon, et al.
Pageof 85